A Study to Evaluate the Quality of Life of Male and Female Adult Patients With Severe Refractory Atopic Dermatitis Treated With Dupilumab in Czech Republic
CompletedOBSERVATIONAL
Enrollment
146
Participants
Timeline
Start Date
December 30, 2022
Primary Completion Date
June 16, 2025
Study Completion Date
June 16, 2025
Conditions
Atopic Dermatitis
Trial Locations (1)
180 81
Investigational Site: Bulovka University Hospital, Prague
NCT05527964 - A Study to Evaluate the Quality of Life of Male and Female Adult Patients With Severe Refractory Atopic Dermatitis Treated With Dupilumab in Czech Republic | Biotech Hunter | Biotech Hunter